101 - 125 of 298
Number of results to display per page
TitleCreatorRelation Is Part Of
101 Interocular Phase Delay Shifts Visual Cortical Dominance: a Potential New Therapeutic Approach for AmblyopiaEric Gaier, Daniel Montgomery, Arnold Heynen, Mark BearNANOS Annual Meeting 2018: Scientific Platform, Session I
102 eFOCUS Phase 2: Comparative Clinical Performance of Smartphone & Traditional FunduscopyHamish Dunn, Samuel Marks, Kai Teo, Christine Kang, Stewart Dunn, Paul Healey, Andrew WhiteNANOS Annual Meeting 2018: Scientific Platform, Session I
103 Safety and Efficacy of an 11β-Hydroxysteroid Dehydrogenase Type-1 Inhibitor (AZD4017) in Idiopathic Intracranial HypertensionKeira Markey, Ryan Ottridge, James Mitchell, Caroline Rick, Rebecca Woolley, Natalie Ives, Tim Matthews, Anita Krishnan, Pushkar Shah, William Scotton, Susan Mollan, Alex SinclairNANOS Annual Meeting 2018: Scientific Platform, Session I
104 Assessment of a Fully-Automated RAPD Test as a Routine Screening ToolLael Stander, Shira Simon, Matthew Thurtell, Michael Wall, Randy KardonNANOS Annual Meeting 2018: Scientific Platform, Session I
105 Ocular Motor Abnormalities during Saccadic Reading in Different Neuro-Ophthalmic DiseasesAngela Oh, Tiffany Chen, Mohammad Shariati, Naz Jehangir, Caroline Yu, Carmel Mercado, Rosa Yu, Joyce LiaoNANOS Annual Meeting 2018: Scientific Platform, Session I
106 Safety/Acuity Outcomes 96-Weeks Post-Treatment with rAAV2/2-ND4; Gene Therapy for ND4 LHON: a Phase I/II TrialBarrett Katz, Catherine Vignal, Celine Bouquet, Nitza Thomasson, Ann Galy, Serge Fitoussi, Jose SahelNANOS Annual Meeting 2018: Scientific Platform, Session I
107 Does optic nerve appearance predict visual outcome in patients with idiopathic intracranial hypertension (IIH)?Jonathan Micieli, Beau Bruce, Caroline Vasseneix, Richard Blanch, Damian Berezovsky, Jason Peragallo, Nancy Newman, Valérie BiousseNANOS Annual Meeting 2018: Scientific Platform, Session I
108 Next Generation Sequencing results in an Italian cohort of hereditary optic neuropathies patientsChiara La Morgia, Francesca Tagliavini, Leonardo Caporali, Michele Carbonelli, Lidia Di Vito, Piero Barboni, Maria Lucia Cascavilla, Arturo Carta, Alessandra Rufa, Stefania Bianchi Marzoli, Francesco Mari, Michelangelo Mancuso, Maria Alice Donati, Anna Maria De Negri, Federico Sadun, Maria Lucia Val...NANOS Annual Meeting 2018: Scientific Platform, Session I
109 Neurological Literature of Neuro-Ophthalmological SignificanceCaroline Tilikete, MD-PhD Hospices Civils de Lyon, University Lyon I Lyon, FranceNANOS Annual Meeting 2018: Literature Review
110 Ophthalmological Literature of Neuro-Ophthalmological SignificanceHelen V Danesh-Meyer, MbChB, MD, PhD, FRANZCO, Department of Ophthalmology, University of Auckland, Auckland, New ZealandNANOS Annual Meeting 2018: Literature Review
111 Literature Review: Developments in Disease Mechanisms and TreatmentLeonard A. Levin, MD, PhD, McGill University, Montreal, CanadaNANOS Annual Meeting 2018: Literature Review
112 Literature Review: Wild CardLynn K Gordon, MD, PhD, Stein Eye Institute, David Geffen School of Medicine at UCLA. Los Angeles, CaliforniaNANOS Annual Meeting 2018: Literature Review
113 Literature Relevant to Optic Nerve and Retinal Ganglion CellsNitza Goldenberg-Cohen, MD, Ophthalmology, Bnai Zion Medical Center; Technion, Israel Institute of Technology, Haifa, IsraelNANOS Annual Meeting 2018: Literature Review
114 Literature Review: Highlights From IOVS 2017Gregory Van Stavern, MD, Department of Ophthalmology and Visual Sciences, Washington University in St. Louis, St. Louis, MONANOS Annual Meeting 2018: Literature Review
115 Neurosurgical Manuscripts of Neuro-Ophthalmological SignificanceNeil R. Miller, MD FACS, Johns Hopkins University School of Medicine, Baltimore, MarylandNANOS Annual Meeting 2018: Literature Review
116 Histiocytosis and Other Oddballs of the OrbitSteven E. Feldon, MD, MBANANOS Annual Meeting 2018: Hot Topics:What's New in the Orbit?
117 Thyroid Eye Disease UpdateJim Garrity, MDNANOS Annual Meeting 2018: Hot Topics:What's New in the Orbit?
118 What's New with Orbital Inflammatory Syndrome: Best Approaches and RxHoward Krauss, MDNANOS Annual Meeting 2018: Hot Topics:What's New in the Orbit?
119 A Rational Approach to Treating Inflammatory Optic Neuropathies: Which Treatment and WhyJeffrey Bennett, MD, PhDHot Topics:What's New in the Optic Nerve?
120 Optic Nerve Deformity as a Possible Contributor to Optic NeuropathyJoseph Demer, MD, PhDHot Topics:What's New in the Optic Nerve?
121 20150225_nanos_mechanicalcausesofstrabismus1_02
122 Overview of the NANOS Practice & Compensation SurveyMeg Guerin-Calvert, President and Senior Managing Director, Center for Healthcare Economic and Policy, FTI Consulting, Inc.NANOS Annual Meeting 2017: Overview of the NANOS Practice & Compensation Survey
123 Radiation Oncology for the Neuro-OphthalmologistScott L. Stafford, MDNANOS Annual Meeting 2017: Radiation Oncology for the Neuro-Ophthalmologist
124 Update on Visual Field Expansion with Rehabilitative Training (video)Krystel Huxlin, PhDNANOS Annual Meeting 2017: Afferent and Efferent Rehabilitative Strategies in Neuro-Ophthalmology
125 Fitting Peripheral Prisms for Hemianopia (video)Eli Peli, MSc, ODNANOS Annual Meeting 2017: Afferent and Efferent Rehabilitative Strategies in Neuro-Ophthalmology
101 - 125 of 298